Add To Watchlist
Share URL
About The Company
Description
Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States.
Read More
Overview
Value
1
Growth
28
Health
47
Management
49
Analyst Opinion
71
Total
39
All Scores Out Of 100
Best Features
- Has a low level of debt
- Liked by analysts
- Low preportion of income is paid as dividend
Risk Factors
- Overvalued on cashflow basis
- Earnings have declined recently
- Income is not covering expenditure and investment
- Earnings are negative
- There is a history of diluting shareholders 0
- No margin of safety at their current market price
- Poor earnings and cashflow growth
- Accounting anomalies: Growing revenues without a corresponding growth in cash flows. 0
Market Peers
SEZI.ST
Key Figures
PE Ratio (TTM)
N/A
Margin Of Safety (DCF)
-110.78%
Revenue Growth (5 Year Average)
20.83%
Ratings Consensus
Buy
Share Buybacks
-2.99%
Dividend Yeild (TTM)
N/A
Valuation
Value Score
1
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Buy Target: < 0.5 SEK ✘
Current Price: 6 SEK
Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.
Price/Earnings
N/Ax
Free Cashflow Yeild
-32.01%
PE/Earnings Growth
N/A
Price/Book
1.40x
Growth
Growth Score
28
- ✔ 5 Year Average Revenue growth of 20.83% is higher than the market average (10.97%)
- ✔ Revenue growth has improved this yeara
- ✘ 5 Year Average Earnings growth of -1.92% is lower than the market average (14.48%)
- ✘ Earnings growth has slowed this year
- ✘ 5 Year Average Free Cashflow growth of -9.47% is lower than the market average (12.35%)
- ✘ Free Cashflow growth has slowed this year
Revenue Growth
20.83%
Earnings Growth
-1.92%
Cashflow Growth
-9.47%
Health
Health Score
47
Altman Z Score
N/A
Piostroski Score
3.00
Debt/Equity
0.05x
Current Assets/Liabilities
2.68x
Free Cashflow/Total Debt
N/Ax
Debt/Capital
0.16x
Management
Management Score
49
Average Buybacks/Dilution
-2.99%
Recent Buybacks/Dilution
1.39%
5 Year Price Volitility
42.04%
Return On Assets
-9.11%
Return On Capital Employed
-2.72%
Return On Equity
-17.40%
Return On Free Cashflow
207.57%
Return On Investments
-1324.74%
Analysts
Analyst Opinion
71
- ✔ Ratings consensus is Buy
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
Other Information
Company Name
Senzime AB (publ)
Currency
SEK
Beta
0.778039
Vol Avg
53753
Ceo
Ms. Pia Renaudin
Cik
Cusip
Exchange
Stockholm Stock Exchange
Full Time Employees
29
Industry
Medical Devices
Sector
Healthcare
Ipo Date
2008-06-18
Address
Ulls vAeg 41
City
Uppsala
State
Country
SE
Zip
756 51
Phone
46 18 51 56 40
All financial data provided by FMP